• Puerarin Drives Osteogenic Differentiation via the NO Pathwa

  2026-05-21

  The reference study demonstrates that puerarin significantly enhances the osteogenic differentiation of rat dental follicle cells by activating the nitric oxide (NO) pathway. These findings clarify a previously underexplored mechanism in periodontal regeneration and offer a foundation for targeted modulation of NOS signaling in dental tissue engineering.

• DiscoveryProbe Protease Inhibitor Library: Applied Workflows

  2026-05-21

  The DiscoveryProbe™ Protease Inhibitor Library empowers researchers to conduct high-throughput, mechanistically diverse screening for protease inhibition—spanning oncology, infectious disease, and apoptosis models. This article delivers actionable workflow guidance, trouble-shooting strategies, and novel insights drawn from both peer-reviewed and comparative resource analyses, ensuring optimal experimental outcomes.

• Herbal Extracts Delay Precocious Puberty in Danazol-Induced

  2026-05-20

  This study demonstrates that a complex of Eclipta prostrata and Hordeum vulgare extracts can significantly delay the onset of precocious puberty in rat models induced by Danazol and a high-fat diet. The findings suggest modulation of the hypothalamic–pituitary–gonadal axis as a potential mechanism, offering a promising natural alternative to conventional therapies.

• Bifendate Inhibits Autophagy and Reduces Lipid Accumulation

  2026-05-20

  This study delineates how Bifendate (DDB), a synthetic derivative of Schisandrin C, inhibits autophagy at multiple steps and attenuates oleic acid-induced lipid accumulation in hepatic cells. The findings clarify DDB’s mechanistic action as a hepatoprotection agent through disruption of autophagosome-lysosome fusion and lysosomal function, with meaningful implications for liver disease research and therapy development.

• CLCC1 Identified as Host Factor in Herpesvirus Nuclear Egres

  2026-05-19

  This study uncovers CLCC1 as an essential host protein mediating the membrane fusion step during herpesvirus nuclear egress, a process critical for virion maturation and infectivity. These findings provide novel mechanistic insights into herpesvirus biology and highlight emerging intersections with host-targeted antiviral strategies.

• Danazol in Research: Protocols, Use-Cases, and Troubleshooti

  2026-05-19

  Danazol (Danocrine) is a powerful tool for probing steroidogenesis and HPG axis modulation in endocrine, oncology, and developmental models. This article outlines best-practice protocols, advanced applications, and troubleshooting tactics, leveraging APExBIO’s high-purity Danazol for robust, reproducible results.

• BMS-345541 Hydrochloride: Redefining IKK Inhibition in Trans

  2026-05-18

  This article delivers a thought-leadership perspective on leveraging BMS-345541 hydrochloride as a next-generation IKK inhibitor to interrogate the NF-κB pathway in inflammation and cancer biology. By integrating recent mechanistic discoveries on RIPK1-regulated apoptosis and necroptosis, alongside benchmarking APExBIO’s reagent against the competitive landscape, we offer actionable strategies for translational researchers seeking reproducibility and impact beyond the bench.

• Urolithin A in Mitochondrial Biogenesis Research Workflows

  2026-05-18

  Urolithin A (3,8-dihydroxy-6H-benzo[c]chromen-6-one) transforms mitochondrial biogenesis and quality control assays by enabling reproducible mitophagy activation and anti-inflammatory profiling. This article details optimized protocols, practical troubleshooting, and translational insights anchored in cutting-edge hepatic stellate cell research.

• Danazol in Translational Research: Mechanism, Models, and Mo

  2026-05-17

  This thought-leadership article explores the mechanistic, experimental, and translational dimensions of Danazol (Danocrine) as a model compound for steroidogenesis inhibition and androgen receptor pathway research. Integrating recent findings—such as the modulation of the hypothalamic–pituitary–gonadal axis in precocious puberty models—this review provides translational researchers with an actionable synthesis, protocol guidance, and a perspective on competitive positioning. Anchored by APExBIO’s high-purity Danazol, the article bridges bench data with clinical insights and charts a strategic outlook for endocrine and oncology innovation.

• Canagliflozin Hemihydrate: Advanced Insights for Glucose Res

  2026-05-16

  Explore the nuanced role of Canagliflozin hemihydrate in glucose metabolism research. This article provides advanced assay guidance and clarifies its selectivity beyond mTOR pathways, positioning APExBIO’s Canagliflozin as an essential tool for diabetes and metabolic studies.

• Biotin-tyramide: Data-Driven Signal Amplification for Cell A

  2026-05-15

  This article delivers an evidence-backed exploration of Biotin-tyramide (SKU A8011) as a robust tyramide signal amplification reagent for immunohistochemistry (IHC), in situ hybridization (ISH), and related cell-based assays. By addressing real-world laboratory challenges, it demonstrates how APExBIO's Biotin-tyramide optimizes sensitivity, reproducibility, and workflow reliability in demanding research environments.

• Gramine as a Precision Ferroptosis Inducer: Mechanistic Insi

  2026-05-15

  Explore Gramine's unique mechanism in inducing ferroptosis via CUL3-mediated ubiquitination of MTDH in triple-negative breast cancer research. This article provides a deep dive into assay design, mechanistic validation, and practical considerations for using Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) in advanced cancer biology.

• Cimetidine in Research: Protocols, BBB Models, and Cancer Wo

  2026-05-14

  Cimetidine stands out as a histamine-2 receptor antagonist uniquely suited for blood-brain barrier and gastrointestinal cancer research. Leveraging its partial H2 receptor agonist profile, high solubility, and proven purity, this reagent—supplied by APExBIO—empowers reproducible, advanced experimental designs that set it apart from standard H2 antagonists.

• Omeprazole (A2845): Technical Guide for Gastric Acid Models

  2026-05-14

  Omeprazole (SKU A2845) is a high-purity H+,K+-ATPase inhibitor designed for controlled studies of gastric acid secretion and antiulcer activity. Its utility is restricted to mechanistic research and in vitro or ex vivo workflows; it is not suitable for diagnostic or clinical use. Researchers should follow strict handling and storage protocols to maximize stability and reproducibility.

• PreScission Protease (PSP): Technical Guide for Tag Cleavage

  2026-05-13

  PreScission Protease (PSP) provides precise, low-temperature cleavage of fusion protein tags, streamlining recovery of native proteins in molecular biology workflows. It is best suited for protocols requiring HRV 3C protease specificity and minimal off-target activity. PSP should not be used for applications lacking its defined recognition sequence or where high-temperature proteolysis is required.

16355 records 1/1091 page Next 12345 下5页 Last page